This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Italfarmaco Spa. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Daniele Barbareschi: Innovator in Pharmaceutical Suspensions
Introduction
Daniele Barbareschi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable aqueous suspensions. His work focuses on enhancing the delivery and efficacy of medications.
Latest Patents
One of Barbareschi's key patents is titled "Riluzole aqueous suspensions - Physically and chemically stable aqueous oral suspensions of riluzole and manufacturing methods thereof." This patent describes suspensions that contain riluzole in particle form, along with a wetting agent, preferably a surfactant. The formulations are designed to contain riluzole in amounts ranging from about 0.1% to about 20% w/v, with an average particle size of less than 200 µm. Notably, these suspensions do not exhibit the known local anaesthetic effects of riluzole.
Career Highlights
Barbareschi is associated with Italfarmaco Spa, a company that specializes in pharmaceutical products. His work at Italfarmaco has been instrumental in advancing the formulation of oral medications, particularly those that require precise delivery mechanisms.
Collaborations
Throughout his career, Barbareschi has collaborated with several professionals in the field, including Tiziano Oldoni and Paolo Mascagni. These collaborations have contributed to the innovative approaches taken in his research and development efforts.
Conclusion
Daniele Barbareschi's contributions to the pharmaceutical industry, particularly through his patent on riluzole aqueous suspensions, highlight his role as an innovator. His work continues to influence the development of effective medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile